Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Contact information

Email
sarah.flannery@ndm.ox.ac.uk

Research groups

Mass Spectrometry for Drug Target Discovery

Sarah Flannery

Research Assistant

Recent publications

Symptom Duration-Dependent Protein Abundance Changes in Symptomatic and Asymptomatic Tendons in Early Stage Unilateral Patellar Tendinopathy.

Steffen D. et al, (2026), J Proteome Res, 25, 2170 - 2182

Acidosis attenuates the hypoxic stabilization of HIF-1α by activating lysosomal degradation.

White B. et al, (2025), J Cell Biol, 224

A novel method to quantify fibrin-fibrin and fibrin-α2-antiplasmin cross-links in thrombi formed from human trauma patient plasma.

Morrow GB. et al, (2024), J Thromb Haemost, 22, 1758 - 1771

STN7 is not essential for developmental acclimation of Arabidopsis to light intensity.

Flannery SE. et al, (2023), Plant J, 114, 1458 - 1474

Discovery of plasma proteome markers associated with clinical outcome and immunological stress after cardiac surgery.

Bello C. et al, (2023), Front Cardiovasc Med, 10

More publications